The University of Chicago Header Logo

Connection

Carrie W. Rinker-Schaeffer to Humans

This is a "connection" page, showing publications Carrie W. Rinker-Schaeffer has written about Humans.
Connection Strength

0.379
  1. In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose. J Vis Exp. 2015 Oct 14; (105):e52721.
    View in: PubMed
    Score: 0.017
  2. Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models. Am J Pathol. 2013 Aug; 183(2):576-91.
    View in: PubMed
    Score: 0.015
  3. Using MKK4's metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization. Cancer Metastasis Rev. 2012 Dec; 31(3-4):605-13.
    View in: PubMed
    Score: 0.014
  4. Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization. Clin Exp Metastasis. 2012 Jun; 29(5):397-408.
    View in: PubMed
    Score: 0.013
  5. Metastasis-suppressor genes in clinical practice: lost in translation? Nat Rev Clin Oncol. 2011 Jun; 8(6):333-42.
    View in: PubMed
    Score: 0.012
  6. Thinking outside the box: using metastasis suppressors as molecular tools. Semin Cancer Biol. 2011 Apr; 21(2):89-98.
    View in: PubMed
    Score: 0.012
  7. In vitro metastatic colonization of human ovarian cancer cells to the omentum. Clin Exp Metastasis. 2010 Mar; 27(3):185-96.
    View in: PubMed
    Score: 0.012
  8. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells. Cancer Lett. 2008 Dec 08; 272(1):12-22.
    View in: PubMed
    Score: 0.010
  9. Societal interactions in ovarian cancer metastasis: a quorum-sensing hypothesis. Clin Exp Metastasis. 2009; 26(1):67-76.
    View in: PubMed
    Score: 0.010
  10. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Res. 2008 Apr 01; 68(7):2166-75.
    View in: PubMed
    Score: 0.010
  11. Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment. Cancer Metastasis Rev. 2008 Mar; 27(1):67-73.
    View in: PubMed
    Score: 0.010
  12. Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines. Mol Cancer Res. 2008 Mar; 6(3):501-8.
    View in: PubMed
    Score: 0.010
  13. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia. J Pathol. 2007 Aug; 212(4):386-94.
    View in: PubMed
    Score: 0.010
  14. Stopping cancer before it colonizes. Nat Med. 2006 Aug; 12(8):887-8.
    View in: PubMed
    Score: 0.009
  15. Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application. Clin Cancer Res. 2006 Jul 01; 12(13):3882-9.
    View in: PubMed
    Score: 0.009
  16. Metastasis suppressor genes: from gene identification to protein function and regulation. Cancer Biol Ther. 2005 Aug; 4(8):805-12.
    View in: PubMed
    Score: 0.008
  17. Metastasis suppressor genes: signal transduction, cross-talk and the potential for modulating the behavior of metastatic cells. Anticancer Drugs. 2004 Jul; 15(6):559-68.
    View in: PubMed
    Score: 0.008
  18. Suppression of metastasis--a new function for known proteins. J Natl Cancer Inst. 2004 Mar 03; 96(5):344-5.
    View in: PubMed
    Score: 0.008
  19. A new look at an old problem: the survival and organ-specific growth of metastases. Sci STKE. 2004 Jan 13; 2004(216):pe3.
    View in: PubMed
    Score: 0.008
  20. Inhibition of prostate cancer metastatic colonization by approximately 4.2 Mb of human chromosome 12. Int J Cancer. 2004 Jan 01; 108(1):15-22.
    View in: PubMed
    Score: 0.008
  21. The basic biology of metastasis. Cancer Treat Res. 2004; 118:1-21.
    View in: PubMed
    Score: 0.008
  22. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol. 2003 Mar; 169(3):1122-33.
    View in: PubMed
    Score: 0.007
  23. MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research. Clin Exp Metastasis. 2003; 20(1):25-30.
    View in: PubMed
    Score: 0.007
  24. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res. 2002 Nov 15; 62(22):6717-23.
    View in: PubMed
    Score: 0.007
  25. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res. 2001 Apr 01; 61(7):2833-7.
    View in: PubMed
    Score: 0.006
  26. Metastasis suppression in prostate cancer. Cancer Metastasis Rev. 2001; 20(3-4):279-86.
    View in: PubMed
    Score: 0.006
  27. Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst. 2000 Nov 01; 92(21):1717-30.
    View in: PubMed
    Score: 0.006
  28. Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1. Commun Biol. 2020 09 22; 3(1):524.
    View in: PubMed
    Score: 0.006
  29. Defining the biologic role of genes that regulate prostate cancer metastasis. Curr Opin Urol. 2000 Sep; 10(5):397-401.
    View in: PubMed
    Score: 0.006
  30. Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res. 2000; 2(6):408-16.
    View in: PubMed
    Score: 0.006
  31. The Dunning model. Prostate. 2000 Jun 01; 43(4):295-302.
    View in: PubMed
    Score: 0.006
  32. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res. 1999 Nov 01; 59(21):5483-7.
    View in: PubMed
    Score: 0.006
  33. What defines a useful marker of metastasis in human cancer? J Natl Cancer Inst. 1999 Aug 18; 91(16):1351-3.
    View in: PubMed
    Score: 0.006
  34. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. Cancer Res. 1998 Nov 01; 58(21):4963-9.
    View in: PubMed
    Score: 0.005
  35. Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potential. Clin Cancer Res. 1998 Oct; 4(10):2391-8.
    View in: PubMed
    Score: 0.005
  36. Identification of a novel metastasis-suppressor region on human chromosome 12. Cancer Res. 1998 Aug 15; 58(16):3561-5.
    View in: PubMed
    Score: 0.005
  37. Prostate cancer metastasis-suppressor genes: a current perspective. In Vivo. 1998 Jan-Feb; 12(1):49-58.
    View in: PubMed
    Score: 0.005
  38. Localization of prostate cancer metastasis-suppressor activity on human chromosome 17. Prostate. 1997 Dec 01; 33(4):271-80.
    View in: PubMed
    Score: 0.005
  39. The role of motility proteins and metastasis-suppressor genes in prostate cancer progression. Stem Cells. 1996 Sep; 14(5):508-16.
    View in: PubMed
    Score: 0.005
  40. Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11. Genomics. 1995 Nov 01; 30(1):105-8.
    View in: PubMed
    Score: 0.004
  41. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res. 1994 Dec 01; 54(23):6249-56.
    View in: PubMed
    Score: 0.004
  42. Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate. 1994 Nov; 25(5):249-65.
    View in: PubMed
    Score: 0.004
  43. SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer. Cancer Cell. 2014 Apr 14; 25(4):455-68.
    View in: PubMed
    Score: 0.004
  44. Molecular and cellular markers for metastatic prostate cancer. Cancer Metastasis Rev. 1993 Mar; 12(1):3-10.
    View in: PubMed
    Score: 0.004
  45. Mechanism of action and regulation of protein synthesis initiation factor 4E: effects on mRNA discrimination, cellular growth rate, and oncogenesis. Prog Nucleic Acid Res Mol Biol. 1993; 46:183-219.
    View in: PubMed
    Score: 0.004
  46. Flexible peritoneal windows for quantitative fluorescence and bioluminescence preclinical imaging. Mol Imaging. 2013 Jan-Feb; 12(1):28-38.
    View in: PubMed
    Score: 0.004
  47. Increased MKK4 abundance with replicative senescence is linked to the joint reduction of multiple microRNAs. Sci Signal. 2009 Oct 27; 2(94):ra69.
    View in: PubMed
    Score: 0.003
  48. FYN is overexpressed in human prostate cancer. BJU Int. 2009 Jan; 103(2):171-7.
    View in: PubMed
    Score: 0.003
  49. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res. 2006 Feb 15; 66(4):2264-70.
    View in: PubMed
    Score: 0.002
  50. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis. 2005; 22(4):319-29.
    View in: PubMed
    Score: 0.002
  51. Adjunctive therapy for men with high risk localized and locally advanced prostate cancer: targeting disseminated tumor cells. J Urol. 2004 Dec; 172(6 Pt 2):2539-44.
    View in: PubMed
    Score: 0.002
  52. Highlights of the Society of Urologic Oncology meeting, June 2, 2001. J Urol. 2002 Aug; 168(2):653-9.
    View in: PubMed
    Score: 0.002
  53. Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn Reson Med. 2001 Jun; 45(6):1046-55.
    View in: PubMed
    Score: 0.002
  54. A G2/M growth arrest response to low-dose intermittent H2O2 in normal uroepithelial cells. Int J Oncol. 2000 Sep; 17(3):425-32.
    View in: PubMed
    Score: 0.001
  55. Mapping of metastasis suppressor genes for prostate cancer by microcell-mediated chromosome transfer. Asian J Androl. 2000 Sep; 2(3):167-71.
    View in: PubMed
    Score: 0.001
  56. Angiogenesis inhibitors. Curr Oncol Rep. 2000 Jan; 2(1):11-6.
    View in: PubMed
    Score: 0.001
  57. In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer. Urology. 1999 Sep; 54(3):573-7.
    View in: PubMed
    Score: 0.001
  58. In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer. Cancer Chemother Pharmacol. 1999; 44(1):81-7.
    View in: PubMed
    Score: 0.001
  59. Human chromosome 16 suppresses metastasis but not tumorigenesis in rat prostatic tumor cells. Cancer Res. 1998 Oct 15; 58(20):4572-6.
    View in: PubMed
    Score: 0.001
  60. Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo. Cancer Chemother Pharmacol. 1998; 41(6):505-12.
    View in: PubMed
    Score: 0.001
  61. Prostate cancer--biology of metastasis and its clinical implications. World J Urol. 1996; 14(3):182-9.
    View in: PubMed
    Score: 0.001
  62. Localization of metastasis suppressor gene(s) for rat prostatic cancer to the long arm of human chromosome 10. Genes Chromosomes Cancer. 1995 Oct; 14(2):112-9.
    View in: PubMed
    Score: 0.001
  63. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 1995 May 12; 268(5212):884-6.
    View in: PubMed
    Score: 0.001
  64. Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F. Mol Cell Biol. 1991 Nov; 11(11):5435-45.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.